Sponsor:University of California, San FranciscoBrief Summary: Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor…
Sponsor:University of Colorado, DenverBrief Summary: This Stage II randomized, controlled, longitudinal trial seeks to assess the acceptability, feasibility, and effects…
Sponsor:Riley Bove, MDBrief Summary: WHO: 40 participants with a confirmed diagnosis of Multiple Sclerosis (MS) able to engage in moderate…
Sponsor:ProgenaBiomeBrief Summary: This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding…
Sponsor:Brainstorm-Cell TherapeuticsBrief Summary: A multidose open-label study with autologous Mesenchymal Stromal Stem Cells Secreting Neurotrophic Factors (MSC-NTF cells) involving 20…
Sponsor:Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyBrief Summary: The study is to evaluate the efficacy…
Sponsor:National Cancer Institute (NCI)Brief Summary: This phase Ib trial studies the side effects of nivolumab and to see how well…
Sponsor:Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyBrief Summary: The study is to evaluate the efficacy…
Sponsor:BiogenBrief Summary: The primary objective is to evaluate the feasibility of the Multiple Sclerosis Performance Test (MSPT) in a clinical…
Sponsor:Novartis PharmaceuticalsBrief Summary: The open label study to evaluate effectiveness of treatment with ofatumumab in patients transitioning from commonly used…
